Structured evidence table for Chlorophyll Gut Health Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Chlorophyll Gut Health Randomized Trial | It was once most popular in Japan; however, in recent years, its use in the food industry has increased significantly []. | 3 | Sławińska Paulina (2026) | Matcha as a Source of Bioactive Compounds: A Review of Health-Promoting Properties and Potential Applications |
| Chlorophyll Gut Health Randomized Trial | Numerous recipes featuring matcha can be found online, and many cafés now offer various flavored versions of this beverage. | 3 | Sławińska Paulina (2026) | Matcha as a Source of Bioactive Compounds: A Review of Health-Promoting Properties and Potential Applications |
| Chlorophyll Gut Health Randomized Trial | Therefore, the aim of this review is to present and critically evaluate available evidence on the composition of matcha and its documented physiological effects, highlighting both its therapeutic potential and existing research gaps. | 3 | Sławińska Paulina (2026) | Matcha as a Source of Bioactive Compounds: A Review of Health-Promoting Properties and Potential Applications |
| Chlorophyll Gut Health Randomized Trial | 1 2 3 3 4 5 5 6 7 8 Table 1 9 Camellia sinensis Tea is one of the most popular beverages in the world. | 3 | Sławińska Paulina (2026) | Matcha as a Source of Bioactive Compounds: A Review of Health-Promoting Properties and Potential Applications |
| Chlorophyll Gut Health Randomized Trial | Chlorella 5 7 8 9 10 Emerging evidence suggests that supplementation withand spirulina may be associated with improvements in metabolic parameters such as insulin sensitivity, lipid profiles, and hepatic steatosis markers while simultaneously reducing systemic inflammatory burden and oxidative stress. | 3 | Rzeski Wojciech (2026) | Chlorella and Arthrospira (Spirulina) as Multi-Pathway Biological Response Modulators: Molecular Mechanisms, Signaling Pathways and Clinical Evidence |
| Chlorophyll Gut Health Randomized Trial | We also discuss clinical evidence, safety considerations, and translational perspectives, highlighting current knowledge gaps and future research directions necessary for the rational development of microalgae-based interventions in preventive and integrative medicine. | 3 | Rzeski Wojciech (2026) | Chlorella and Arthrospira (Spirulina) as Multi-Pathway Biological Response Modulators: Molecular Mechanisms, Signaling Pathways and Clinical Evidence |
| Chlorophyll Gut Health Randomized Trial | 2 7 19 In spirulina, phycobiliproteins, particularly phycocyanin, are the dominant pigment-derived bioactives, with documented antioxidant and anti-inflammatory activity and emerging evidence for metabolic signaling effects including Nrf2 activation and the attenuation of oxidative stress in preclinical models [,,]. | 3 | Rzeski Wojciech (2026) | Chlorella and Arthrospira (Spirulina) as Multi-Pathway Biological Response Modulators: Molecular Mechanisms, Signaling Pathways and Clinical Evidence |
| Chlorophyll Gut Health Randomized Trial | Chlorella Arthrospira Microalgae represent a diverse group of aquatic photosynthetic microorganisms and a rich source of bioactive compounds with significant potential in functional foods, nutraceuticals, and preventive medicine. | 3 | Rzeski Wojciech (2026) | Chlorella and Arthrospira (Spirulina) as Multi-Pathway Biological Response Modulators: Molecular Mechanisms, Signaling Pathways and Clinical Evidence |
Source documents